Harvest Group Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Harvest Group Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-123	Closed	-$1K	–	816
2020 Q2	$1K	Hold	123	–	–	﹤0.01%	423
2020 Q1	$1K	Hold	123	–	–	﹤0.01%	437
2019 Q4	$1K	Hold	123	–	–	﹤0.01%	872
2019 Q3	$1K	Hold	123	–	–	﹤0.01%	928
2019 Q2	$1K	Hold	123	–	–	﹤0.01%	816
2019 Q1	$2K	Buy	+123	New	+$2.17K	﹤0.01%	681

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Harvest Group Wealth Management's TEVA Position: Q3 2020 in Review

Harvest Group Wealth Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 123 shares — an estimated $1K sold.

Harvest Group Wealth Management first reported a position in TEVA in Q1 2019 and held it in 6 quarters. The position peaked at $2K in Q1 2019. 443 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

Harvest Group Wealth Management reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Harvest Group Wealth Management sold 123 Teva Pharmaceuticals shares in Q3 2020, an estimated $1K.
Harvest Group Wealth Management first reported a position in Teva Pharmaceuticals in Q1 2019 and held it in 6 quarters.
Harvest Group Wealth Management's Teva Pharmaceuticals position peaked at $2K in Q1 2019.
443 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Harvest Group Wealth Management's 13F filing for Q3 2020, filed 9 Nov 2020.